Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
A Multicentre, Randomized, Double-blind, Parallel-group, Controlled Study, to Assess the Efficacy and Safety of P-3074 Cutaneous Spray, Solution, in the Treatment of Male Pattern Baldness
In the register
The register attaches this trial to Topical finasteride (Almirall), currently at “Approved” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Completed
- Declared phase
- Phase 3
- Sponsor
- Polichem S.A.
- Participants (registry)
- 458
- Start
- August 2016
- Primary completion
- March 2018
- Study completion
- March 2018
- Last registry update
- June 2019
- Countries
- Belgium, Germany, Hungary, Russia, Spain
Conditions studied: Alopecia, Androgenetic
Interventions: P-3074, finasteride topical solution, Finasteride, Propecia, P-3074 Vehicle, Vehicle of P-3074, Finasteride Placebo, Placebo of Finasteride
Other trials of Topical finasteride
Various Procedural Treatment Options for Androgenetic Alopecia
A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)
Photosensitization Study in Androgenetic Alopecia
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.